Found: 20
Select item for more details and to access through your institution.
High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients.
- Published in:
- 2009
- By:
- Publication type:
- clinical trial
Pure red cell aplasia associated with hemolytic anemia refractory to standard measures and resolved by rituximab in an elderly patient.
- Published in:
- 2008
- By:
- Publication type:
- Case Study
Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Dysgeusia in patients with hematological malignancies: a reminder for hematologist.
- Published in:
- Journal of Oral Pathology & Medicine, 2013, v. 42, n. 4, p. 352, doi. 10.1111/jop.12034
- By:
- Publication type:
- Article
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 160, doi. 10.1111/ejh.13086
- By:
- Publication type:
- Article
Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 3, p. 276, doi. 10.1111/j.1600-0609.2012.01814.x
- By:
- Publication type:
- Article
Characterization of Ph-Negative Abnormal Clones Emerging During Imatinib Therapy.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 12, p. 2466, doi. 10.1002/cncr.22699
- By:
- Publication type:
- Article
Bortezomib-related colon mucositis in a multiple myeloma patient.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Palliative sedation therapy in a bone marrow transplant unit.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Maintenance Therapy vs Re-treatment at Biochemical Relapse vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II, Randomized Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e271, doi. 10.1016/j.clml.2019.09.447
- By:
- Publication type:
- Article
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA).
- Published in:
- 2010
- By:
- Publication type:
- Letter
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: A multicenter, open label phase 1/2 study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 5, p. 971, doi. 10.1002/cncr.27820
- By:
- Publication type:
- Article
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 22, p. 5544, doi. 10.1002/cncr.27657
- By:
- Publication type:
- Article
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
- Published in:
- Acta Haematologica, 2018, v. 140, n. 4, p. 231, doi. 10.1159/000493880
- By:
- Publication type:
- Article
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
- Published in:
- EJHaem, 2022, v. 3, n. 1, p. 121, doi. 10.1002/jha2.359
- By:
- Publication type:
- Article